Certolizumab Pegol Treatment in Patients With Crohn’s Disease: Final Safety Data From the SECURE Registry

Gary R Lichtenstein, Scott D Lee, Brian G Feagan, Edward V Loftus, Samson Ng, Kaitlin Dehlin, Paul Quinn, Jason Coarse, Theresa Rosario-Jansen, Catherine Arendt, Jeffrey L Stark

Open source

DOI: 10.1093/crocol/otae083
Published: 2024-12-30
Container: Crohn's & Colitis 360
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/crocol/otae083,
  title = {Certolizumab Pegol Treatment in Patients With Crohn’s Disease: Final Safety Data From the SECURE Registry},
  author = {Gary R Lichtenstein and Scott D Lee and Brian G Feagan and Edward V Loftus and Samson Ng and Kaitlin Dehlin and Paul Quinn and Jason Coarse and Theresa Rosario-Jansen and Catherine Arendt and Jeffrey L Stark},
  year = {2024},
  journal = {Crohn's \&amp; Colitis 360},
  doi = {10.1093/crocol/otae083},
  url = {https://doi.org/10.1093/crocol/otae083}
}

RIS

TY  - JOUR
TI  - Certolizumab Pegol Treatment in Patients With Crohn’s Disease: Final Safety Data From the SECURE Registry
AU  - Gary R Lichtenstein
AU  - Scott D Lee
AU  - Brian G Feagan
AU  - Edward V Loftus
AU  - Samson Ng
AU  - Kaitlin Dehlin
AU  - Paul Quinn
AU  - Jason Coarse
AU  - Theresa Rosario-Jansen
AU  - Catherine Arendt
AU  - Jeffrey L Stark
PY  - 2024
JO  - Crohn's &amp; Colitis 360
DO  - 10.1093/crocol/otae083
UR  - https://doi.org/10.1093/crocol/otae083
ER  -

APA

Lichtenstein, G. R., Lee, S. D., Feagan, B. G., Loftus, E. V., Ng, S., Dehlin, K., Quinn, P., Coarse, J., Rosario-Jansen, T., Arendt, C., & Stark, J. L. (2024). Certolizumab Pegol Treatment in Patients With Crohn’s Disease: Final Safety Data From the SECURE Registry. Crohn's & Colitis 360. https://doi.org/10.1093/crocol/otae083

Source records

crossref · retrieved 2026-09-27T02:38:23.932Z